Evaluation of COVID-19 Cases Who Received Immunosuppressive Therapy at a Tertiary Care Hospital

IF 0.3 Q3 MEDICINE, GENERAL & INTERNAL
Merve Sefa Sayar, A. Acar, D. Bulut, S. Çelik, E. Oguz
{"title":"Evaluation of COVID-19 Cases Who Received Immunosuppressive Therapy at a Tertiary Care Hospital","authors":"Merve Sefa Sayar, A. Acar, D. Bulut, S. Çelik, E. Oguz","doi":"10.36519/kd.2022.3538","DOIUrl":null,"url":null,"abstract":"Objective: Immunosuppressive drugs are included in the treatment protocols of severe COVID-19 cases that may present with cytokine storm. In this study, we aimed to examine the characteristics of COVID-19 patients who received immunosuppressive therapy Methods: Patients diagnosed with COVID-19 and followed in the quarantine wards of our hospital between 01.03.2020-24.05.2020 were included in the study. Patient information was obtained retrospectively from patient files and discharge reports, and 263 COVID-19 patients -aged 18 and over- were included in the study.","PeriodicalId":44309,"journal":{"name":"Klimik Journal","volume":null,"pages":null},"PeriodicalIF":0.3000,"publicationDate":"2022-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klimik Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/kd.2022.3538","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Immunosuppressive drugs are included in the treatment protocols of severe COVID-19 cases that may present with cytokine storm. In this study, we aimed to examine the characteristics of COVID-19 patients who received immunosuppressive therapy Methods: Patients diagnosed with COVID-19 and followed in the quarantine wards of our hospital between 01.03.2020-24.05.2020 were included in the study. Patient information was obtained retrospectively from patient files and discharge reports, and 263 COVID-19 patients -aged 18 and over- were included in the study.
某三级医院新冠肺炎患者免疫抑制治疗评价
目的:将免疫抑制药物纳入可能出现细胞因子风暴的COVID-19重症病例的治疗方案。在本研究中,我们旨在研究接受免疫抑制治疗的COVID-19患者的特征。方法:纳入2020年1月3日至2020年5月24日期间在我院隔离病房诊断为COVID-19并随访的患者。回顾性地从患者档案和出院报告中获取患者信息,并将263例年龄在18岁及以上的COVID-19患者纳入研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Klimik Journal
Klimik Journal MEDICINE, GENERAL & INTERNAL-
CiteScore
0.60
自引率
33.30%
发文量
39
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信